April 12, 2022
Dirix L et al. Breast Cancer Research and Treatments, 2022
Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer
You might also be interested by
News
CellCarta and Pillar Biosciences Accelerate FGFR NGS Assay from RUO to IUO for Global Phase 3 Oncology Trial
June 23, 2026
More infoCase Studies & Whitepapers
Improved whole transcriptome sequencing for challenging clinical samples: A streamlined alternative to targeted RNA-seq
June 15, 2026
More info